Protein Chip Market Size is Expected to Reach USD 4.79 Billion by 2035 Owing to the Rapid Adoption of Mass-screening Proteomics Technologies Globally | SNS Insider
U.S. Protein Chip Market was valued at USD 0.96 billion in 2025 and is expected to reach USD 1.87 billion by 2035 due to world-class academic and research infrastructure
Austin, April 01, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Protein Chip Market size was valued at USD 2.46 billion in 2025 and is expected to reach USD 4.79 billion by 2035, growing at a CAGR of 6.89% over 2026-2035.
The rapid adoption of mass-screening proteomics technologies, ongoing investment in marker discovery programs, and increased use of protein microarray platforms in clinical diagnostics and pharmaceutical drug development pipelines are driving the steady and robust growth of the global protein chip market.
Protein Chip Market Size and Forecast:
- Market Size in 2025: USD 2.46 billion
- Market Size by 2035: USD 4.79 billion
- CAGR: 6.89% from 2026 to 2035
- Base Year: 2025
- Forecast Period: 2026–2035
- Historical Data: 2022–2024
Get a Sample Report of Protein Chip Market Forecast @ https://www.snsinsider.com/sample-request/6923
The U.S. Protein Chip Market was valued at USD 0.96 billion in 2025 and is expected to reach USD 1.87 billion by 2035, growing at a CAGR of 6.92% over 2026-2035.
world-class academic and research infrastructure, the most concentrated density of pharmaceutical and biotechnological companies, and continuous federal support of proteomic and precision medicine research through NIH, NCI, or DARPA efforts drive the market growth globally.
Expanding Proteomics Research and Biomarker Discovery Investments to Boost Protein Chip Market Expansion Globally
The biggest structural growth driver for the protein chip market is the rising worldwide investment in proteomics research, biomarker development programs, and precision oncology projects. Protein microarray platforms have unmatched throughput advantages over conventional technologies like Western blotting and enzyme-linked immunosorbent assays (ELISA) because they enable the simultaneous characterization of thousands of protein interactions, post-translational modifications, and disease-associated expression patterns in a single experimental workflow. CROs, academic medical centers, and biopharmaceutical manufacturers worldwide will purchase more high-density protein chip systems due to the growing demand for companion diagnostics, the integration of liquid biopsy with drug development pipelines, and the generation of multi-omic data across TRP and medicinal oncology.
Protein Chip Market Segmentation Analysis:
By Type
In 2025, analytical microarrays held the largest revenue share, nearly 42.18%, due to their established use for antibody profiling, protein expression analysis, and clinical biomarker validation globally. During 2026-2035, the highest CAGR ~ 8.14% is anticipated to be achieved by the reverse phase protein microarray segment propelled by accelerating clinical uptake in oncology tissue profiling globally.
By Application
The proteomics segment accounted for the largest revenue share of around 34.76% in 2025, driven by the essential function of protein microarrays as enabling technologies for high-throughput protein expression profiling. The share of antibody characterization remained constant over around 27.43% in 2025, owing to demand monoclonal antibody developers and biosimilar manufacturers for high-throughput epitope mapping and cross-reactivity assessment solutions.
By End-Use
The largest end-use share was 37.93% for pharmaceutical and biotechnology companies in 2025 driven by high institutional investment in the protein microarray platform globally. The fastest growing segment, in terms of revenue, is diagnostic laboratories and is anticipated to reach a CAGR of nearly 8.97% till 2035, as a result of the continual movement of validated protein microarray assays into accredited clinical laboratory workflows globally.
Get Expert-Led Insights for Your Business Strategy — Connect with Analysts Now @ https://www.snsinsider.com/request-analyst/6923
Protein Chip Market Regional Insights:
Protein Chip Market in Asia Pacific projected to reach USD 8.30 billion USD million in market value growing at quickest growth rate of 9.12% over the forecast period, owing to growing pharmaceutical and biotechnology manufacturing sector in China, India, Japan, South Korea.
Protein Chip Market Revenue by Region, 2022 – 2025 (USD Million) North America accounted for the largest revenue share of 41.06% in 2025 of the protein chip market, due to the unprecedented presence of top protein microarray technology developers.
Europe accounts for a major share of the global protein chips market sales, making it the second-largest regional market. The key factors attributing for this stimulation such as the strong academic tradition in proteomics research and significant Horizon Europe-based funding supporting life science technology development.
Major Players Analysis Listed in the Protein Chip Market Report:
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- Merck KGaA (MilliporeSigma)
- Cytiva (formerly GE Healthcare Life Sciences)
- Full Moon BioSystems, Inc.
- RayBiotech Life, Inc.
- Luminex Corporation (DiaSorin Company)
- Sengenics Corporation
- Proteagen AG
- Randox Laboratories Ltd.
- Bruker Corporation
- Revvity, Inc. (formerly PerkinElmer)
- Creative Biolabs
- Abnova Corporation
- Grace Bio-Labs, Inc.
- Quanterix Corporation
- Arrayit Corporation
- Microarrays Inc.
Protein Chip Market Recent Developments:
- In February 2025, Thermo Fisher Scientific launched an expanded ProtoArray Human Protein Microarray platform featuring over 9,400 unique human proteins with enhanced surface chemistry for improved signal-to-noise performance, targeting pharmaceutical antibody characterization and autoimmune biomarker discovery applications across global research customers.
- In June 2024, Agilent Technologies announced a strategic partnership with a leading the U.S. oncology research consortium to deploy reverse phase protein microarray platforms across 12 NCI-designated cancer centers, supporting large-scale tumor proteome characterization and biomarker validation studies within the consortium’s precision oncology program.
Purchase Comprehensive Protein Chip Market Report – Single User PDF @ https://www.snsinsider.com/checkout/6923
Exclusive Sections of the Report (The USPs):
- RESEARCH FUNDING & PIPELINE INVESTMENT METRICS – helps you understand the scale and direction of global proteomics funding, grant activity, and R&D intensity, highlighting innovation hotspots and future pipeline strength.
- PLATFORM PERFORMANCE & TECHNOLOGY BENCHMARKING – helps you evaluate different protein chip technologies based on sensitivity, specificity, multiplexing capacity, and cost-efficiency for informed technology selection.
- CLINICAL ADOPTION & REGULATORY APPROVAL METRICS – helps you track regulatory clearances (FDA, CE-IVD) and clinical uptake, providing insights into commercialization readiness and market entry barriers.
- END-USER PROCUREMENT & UTILIZATION METRICS – helps you analyze purchasing trends, consumable spending, and usage patterns across pharma, research institutes, and clinical labs.
- DETECTION TECHNOLOGY ADOPTION ANALYSIS – helps you identify the shift between label-free and fluorescence-based detection methods, uncovering emerging technological preferences.
- OUTSOURCING VS. IN-HOUSE UTILIZATION TRENDS – helps you assess operational strategies adopted by pharmaceutical companies, indicating cost optimization and capability development trends.
Protein Chip Market Report Scope
| Report Attributes | Details |
| Market Size in 2025 | USD 2.46 Billion |
| Market Size by 2035 | USD 4.79 Billion |
| CAGR | CAGR of 6.89% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Key Segments | • By Type [Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays] • By Application [Antibody Characterization, Clinical Diagnostics, Proteomics, Others] • By End-use [Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies] |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Rising Demand for Protein Chip Market Data, Our Full Report Trend Analysis @ https://www.snsinsider.com/reports/protein-chip-market-6923
Other Related Report:
Point-of-Care Diagnostics Market
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Data Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. UKNewshour.com takes no editorial responsibility for the same.
